SCHEMBL17695748

SCHEMBL17695748

CC(=O)OCC1OC(OC(C)=O)[C@@H](O)C(O)[C@H]1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.49
▸ THRB P10828 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ PRKD3 O94806 1/20 0.46
▸ PRKCG P05129 1/20 0.46
▸ PRKCB P05771 1/20 0.46
▸ PRKCA P17252 1/20 0.46
▸ PRKCH P24723 1/20 0.46
▸ PRKCI P41743 1/20 0.46
▸ PRKCE Q02156 1/20 0.46
▸ PRKCQ Q04759 1/20 0.46
▸ PRKCZ Q05513 1/20 0.46
▸ PRKCD Q05655 1/20 0.46
▸ PRKD1 Q15139 1/20 0.46
▸ TLR4 O00206 1/20 0.43
▸ CA2 P00918 6/20 0.42
▸ GAA P10253 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ TSHR P16473 2/20 0.41
▸ NR3C1 P04150 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16561877 1.00 CYP2D6 (0.49) CYP2D6THRBHSD17B10PRKD3PRKCG
SCHEMBL16561886 1.00 CYP2D6 (0.49) CYP2D6THRBHSD17B10PRKD3PRKCG
SCHEMBL17683644 1.00 CYP2D6 (0.49) CYP2D6THRBHSD17B10PRKD3PRKCG
SCHEMBL17020327 1.00 CYP2D6 (0.49) CYP2D6THRBHSD17B10PRKD3PRKCG
SCHEMBL16361986 0.94 CYP2D6 (0.45) CYP2D6THRBHSD17B10PRKD3PRKCG
SCHEMBL16361966 0.94 CYP2D6 (0.45) CYP2D6THRBHSD17B10PRKD3PRKCG
SCHEMBL17853203 0.90 CYP2D6 (0.48) CYP2D6THRBHSD17B10PRKD3PRKCG
SCHEMBL16361965 0.90 CYP2D6 (0.48) CYP2D6THRBHSD17B10PRKD3PRKCG
SCHEMBL17695747 0.90 CYP2D6 (0.48) CYP2D6THRBHSD17B10PRKD3PRKCG
SCHEMBL16361988 0.90 CYP2D6 (0.48) CYP2D6THRBHSD17B10PRKD3PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160108076-A1 MODULAR SYNTHESIS OF AMPHIPHILIC JANUS GLYCODENDRIMERS AND THEIR SELF-ASSEMBLY INTO GLYCODENDRIMERSOMES NATIONAL SCIENCE FOUNDATION 2016-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108076-A1 MODULAR SYNTHESIS OF AMPHIPHILIC JANUS GLYCODENDRIMERS AND THEIR SELF-ASSEMBLY INTO GLYCODENDRIMERSOMES C1S, PYM1, DEGS1 CYP2D6 276/4885THRB 3830/4885HSD17B10 2814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback